A PTPN11 mutation was common in diagnosed patients with secondary AML (Makishima et al., 2017), relapsed pediatric AML (Farrar et al., 2016), and acute lymphoblastic leukemia (ALL; Oshima et al., 2016). The gene discussed is PTPN11; the disease is acute lymphoblastic leukemia.